Health Care Industry
Industry: Email Alert RSS FeedMylan, Watson get BuSpar approvals
Drug Store News, April 23, 2001
Mylan Laboratories won approval to market a 15 mg version of buspirone, the generic name of Bristol-Myers Squibb's BuSpar anti-anxiety drug. Watson Pharmaceuticals will market 5 mg and 10 mg versions of the drug. Both companies have exclusive marketing rights to the drug (respectively) for 180 days.
Most RecentHealth Care Articles
- New Mexico Information Exchange Shows Potential of Obama HIT Campaign
- House Health-Care Reform Bill Deserves Public Support
- Caremark Dilutes CVS' Financial Appeal
- Healthcare Roundup: Tenet Loses $3M, AAFP-Coke Deal Draws Protests, Device...
- Individual Mandates in Reform Bills Have Serious Flaws
- More »
The approval, handed down by the U.S. District Court in Washington, ends BMS's unsuccessful bid to extend its BuSpar patent.
COPYRIGHT 2001 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- La anemia falciforme - causas y tratamiento
Most Popular Health Publications
Content provided in partnership with
